590 related articles for article (PubMed ID: 28588076)
1. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
[TBL] [Abstract][Full Text] [Related]
3. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes.
Macfelda K; Weiss TW; Kaun C; Breuss JM; Zorn G; Oberndorfer U; Voegele-Kadletz M; Huber-Beckmann R; Ullrich R; Binder BR; Losert UM; Maurer G; Pacher R; Huber K; Wojta J
J Mol Cell Cardiol; 2002 Dec; 34(12):1681-91. PubMed ID: 12505065
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyocyte PAI-1 influences the cardiac transcriptome and limits the extent of cardiac fibrosis in response to left ventricular pressure overload.
Ghosh AK; Kalousdian AA; Shang M; Lux E; Eren M; Keating A; Wilsbacher LD; Vaughan DE
Cell Signal; 2023 Apr; 104():110555. PubMed ID: 36584735
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
Krag S; Danielsen CC; Carmeliet P; Nyengaard J; Wogensen L
Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
[TBL] [Abstract][Full Text] [Related]
7. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
Zhang Y; Yan H; Guang GC; Deng ZR
Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886
[TBL] [Abstract][Full Text] [Related]
8. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
Knier B; Cordasic N; Klanke B; Heusinger-Ribeiro J; Daniel C; Veelken R; Hartner A; Hilgers KF
J Hypertens; 2011 Aug; 29(8):1602-12. PubMed ID: 21610512
[TBL] [Abstract][Full Text] [Related]
9. Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition.
Ghosh AK; Bradham WS; Gleaves LA; De Taeye B; Murphy SB; Covington JW; Vaughan DE
Circulation; 2010 Sep; 122(12):1200-9. PubMed ID: 20823384
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
[TBL] [Abstract][Full Text] [Related]
11. Identification of Cardiac Fibrosis in Young Adults With a Homozygous Frameshift Variant in SERPINE1.
Khan SS; Shah SJ; Strande JL; Baldridge AS; Flevaris P; Puckelwartz MJ; McNally EM; Rasmussen-Torvik LJ; Lee DC; Carr JC; Benefield BC; Afzal MZ; Heiman M; Gupta S; Shapiro AD; Vaughan DE
JAMA Cardiol; 2021 Jul; 6(7):841-846. PubMed ID: 33439236
[TBL] [Abstract][Full Text] [Related]
12. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
[TBL] [Abstract][Full Text] [Related]
13. Global gene expression profiling in PAI-1 knockout murine heart and kidney: molecular basis of cardiac-selective fibrosis.
Ghosh AK; Murphy SB; Kishore R; Vaughan DE
PLoS One; 2013; 8(5):e63825. PubMed ID: 23724005
[TBL] [Abstract][Full Text] [Related]
14. Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
Zaman AK; Fujii S; Goto D; Furumoto T; Mishima T; Nakai Y; Dong J; Imagawa S; Sobel BE; Kitabatake A
J Mol Cell Cardiol; 2004 Aug; 37(2):525-35. PubMed ID: 15276022
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
[TBL] [Abstract][Full Text] [Related]
16. Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling.
Zhang H; Wu J; Dong H; Khan SA; Chu ML; Tsuda T
Clin Sci (Lond); 2014 Feb; 126(4):275-88. PubMed ID: 23841699
[TBL] [Abstract][Full Text] [Related]
17. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
18. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene.
Hageman J; Eggen BJ; Rozema T; Damman K; Kampinga HH; Coppes RP
Clin Cancer Res; 2005 Aug; 11(16):5956-64. PubMed ID: 16115939
[TBL] [Abstract][Full Text] [Related]
19. Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β1) signaling axis.
Mascareno E; Galatioto J; Rozenberg I; Salciccioli L; Kamran H; Lazar JM; Liu F; Pedrazzini T; Siddiqui MA
J Biol Chem; 2012 Apr; 287(16):13084-93. PubMed ID: 22308025
[TBL] [Abstract][Full Text] [Related]
20. Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling.
Sato T; Kadowaki A; Suzuki T; Ito H; Watanabe H; Imai Y; Kuba K
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]